These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28073513)

  • 1. A fatal drug interaction.
    Albízuri-Prado MF; Sánchez-Orta A; Gómez-Fernández C; Arranz Sánchez D; Herranz Pinto P
    Med Clin (Barc); 2017 Nov; 149(9):e47. PubMed ID: 28073513
    [No Abstract]   [Full Text] [Related]  

  • 2. A life-threatening drug-drug interaction between capecitabine and brivudine in a patient with metastatic breast cancer.
    Tsifi A; Papaxoinis G; Diamantopoulos P; Mantzourani M; Antoniadou V; Halioti A; Gogas H
    J Chemother; 2019; 31(7-8):424-427. PubMed ID: 31516092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal drug-drug interaction of brivudine and capecitabine.
    Rätz Bravo AE; Hofer S; Krähenbühl S; Ludwig C
    Acta Oncol; 2009; 48(4):631-3. PubMed ID: 19165642
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lethal interaction between 5-fluorouracil and brivudine].
    García Herrera AN; Moncayola Vicén JC
    An Sist Sanit Navar; 2018 Aug; 41(2):277-278. PubMed ID: 29943764
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fatal drug-drug interaction between 5-fluorouracil and brivudine].
    García Fernández V; Garrido Arévalo M; Labrada González E; Hidalgo Correas FJ
    Farm Hosp; 2013; 37(1):72-3. PubMed ID: 23461503
    [No Abstract]   [Full Text] [Related]  

  • 6. [Non-fatal drug-drug interaction between capecitabine and brivudine].
    Baena Cañada JM; Martínez-Bautista MJ; Cortés-Carmona C; González-Carrascosa Vega T
    Farm Hosp; 2013; 37(4):342-3. PubMed ID: 24010699
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of brivudine with capecitabine: A case of serious toxicity.
    Drositis I; Kontopodis E; Saloustros E; Androulakis N
    J BUON; 2019; 24(6):2579. PubMed ID: 31983140
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxicity Associated with Capecitabine in Patients Suffering from Dihydropyrimidine Dehydrogenase Deficiency.
    Bermejo-Pérez MJ; Galeote-Miguel AM; Rodelo-Haad LE; Alés-Díaz I; Durán-Ogalla G; Benavides-Orgaz M
    Chemotherapy; 2014; 60(5-6):353-5. PubMed ID: 26330092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capecitabine and adermatoglyphia: trouble in border!
    Mazza C; Slimano F; Visseaux L; Ordan MA; Botsen D; Grange F; Bouche O
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e283-e284. PubMed ID: 27859657
    [No Abstract]   [Full Text] [Related]  

  • 10. Capecitabine leukoencephalopathy.
    Yasiry Z; Obeda MS; Batty R; Sharrack B
    Pract Neurol; 2019 Jun; 19(3):270-271. PubMed ID: 30612099
    [No Abstract]   [Full Text] [Related]  

  • 11. Brivudine induced coronary vasospasm as a manifestation of Kounis syndrome: First report.
    Buturak A; Norgaz T; Gorgulu S
    Int J Cardiol; 2015 Apr; 185():4-6. PubMed ID: 25777280
    [No Abstract]   [Full Text] [Related]  

  • 12. Capecitabine-induced Leukoencephalopathy.
    Yoshimura K; Tokunaga S; Daga H; Inoue M
    Intern Med; 2019 Feb; 58(4):621-622. PubMed ID: 30333392
    [No Abstract]   [Full Text] [Related]  

  • 13. Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C.
    Lens S; Calleja JL; Campillo A; Carrión JA; Broquetas T; Perello C; de la Revilla J; Mariño Z; Londoño MC; Sánchez-Tapias JM; Urbano-Ispizua Á; Forns X
    World J Gastroenterol; 2015 May; 21(17):5421-6. PubMed ID: 25954117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed Drug Eruption Late in the Course of Capecitabine Therapy.
    Del Rosario M; Tsai H; Dasanu CA
    Conn Med; 2016 Apr; 80(4):223-5. PubMed ID: 27265926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capecitabine-Associated Myocardial Infarction.
    Tariq Z; Mudge R; Phillips S
    Am J Ther; 2018; 25(6):e737-e739. PubMed ID: 29894324
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of scars in capecitabine induced hand foot syndrome.
    Singh BSTP; Tripathy T; Kar BR; Singh S
    Indian J Dermatol Venereol Leprol; 2018; 84(1):85-87. PubMed ID: 29210360
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful use of uridine triacetate (Vistogard) three weeks after capecitabine in a patient with homozygous dihydropyrimidine dehydrogenase mutation: A case report and review of the literature.
    Zurayk M; Keung YK; Yu D; Hu EH
    J Oncol Pharm Pract; 2019 Jan; 25(1):234-238. PubMed ID: 28950804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine, a possible reason of sudden cardiac death.
    Ridruejo R; Gonzalez C; Jorge R
    Med Clin (Barc); 2017 Feb; 148(3):143-144. PubMed ID: 27939916
    [No Abstract]   [Full Text] [Related]  

  • 19. Azathioprine plus ribavirin treatment and pancytopenia.
    Chaparro M; Trapero-Marugán M; Moreno-Otero R; Gisbert JP
    Aliment Pharmacol Ther; 2009 Nov; 30(9):962-3. PubMed ID: 19807727
    [No Abstract]   [Full Text] [Related]  

  • 20. Rechallenging 5-Fluorouracil in a Patient With Capecitabine-Induced Ventricular Fibrillation.
    Lai S; Marshall JL; Morrissey RL
    Clin Colorectal Cancer; 2015 Sep; 14(3):198-201. PubMed ID: 25858685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.